Show simple item record

dc.contributor.authorPeter, R.
dc.contributor.authorLuzio, S.D.
dc.contributor.authorDunseath, G.
dc.contributor.authorMiles, Andy
dc.contributor.authorHare, Barry
dc.contributor.authorBackx, Karianne
dc.contributor.authorPauvaday, V.
dc.contributor.authorOwens, D.R.
dc.date.accessioned2008-10-17T11:30:49Z
dc.date.available2008-10-17T11:30:49Z
dc.date.issued2005-03-01en_US
dc.identifier.citationPeter, R., Luzio, S.D., Dunseath, G., Miles, A., Hare, B., Backx, K., Pauvaday, V. and Owens, D.R. (2005) 'Effects of exercise on the absorption of insulin glargine in patients with type 1 diabetes', Diabetes Care, 28(3), pp.560-565en_US
dc.identifier.issn0149-5992
dc.identifier.urihttp://hdl.handle.net/10369/491
dc.description.abstractPrevious studies into the effect of exercise on the absorption of subcutaneously injected long-acting insulin have been conflicting. This study suggests that insulin glargine can be safely and effectively administrated without a dose change during sub-maximal exercise. The findings have implications for people prescribing, and patients with type I diabetes. Backx contributed to the design of the study, the data collection, the data analysis, and edited the manuscript.en_US
dc.publisherAmerican Diabetes Associationen_US
dc.relation.ispartofseriesDiabetes Careen
dc.titleEffects of exercise on the absorption of Insulin Glargine in patients with Type 1 Diabetesen_US
dc.identifier.doihttps://doi.org/10.2337/diacare.28.3.560


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following collection(s)

Show simple item record